CurrentEndo coverage · page 17 of 33
Cardiovascular Diabetology
Latest from Cardiovascular Diabetology
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
ApoC-III proteoforms are associated with better lipid, inflammatory, and glucose profiles independent of total apoC-III
Cross-sectional studyLipids & liver
Cardiovasc Diabetol
Elevated whole blood viscosity is associated with an impaired insulin-stimulated myocardial glucose metabolism
Cross-sectional studyT2D & other
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Biomarkers of glucose-insulin homeostasis and incident type 2 diabetes and cardiovascular disease: results from the Vitamin D and Omega-3 trial
Randomized controlled trialT2D & other
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol